Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03142529Phase 2Unknown
Phase 2, open-label trial in chronic kidney disease (CKD) and end-stage kidney disease (ESKD) (2 arms). Primary endpoints: Change of glomerular filtration rate index at Day 11 and Change of intestinal flora at Day 11. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03142529.